The Southeastern Medical Device Association (SEMDA) annual conference is the region’s premier medical device forum- fostering business and educational opportunities for investors, medical device companies, medical entrepreneurs, and related industry professionals in the Southeast. This two day event provides access to the whole of the Southeast’s medtech resources which is why this conference is of keen interest to Dilon Devices. We are excited to not only attend the 2017 edition, but also be represented on the conference program by our CEO, Lori Chmura.
Here are a few reasons why we are looking forward to #SEMDA2017 in Atlanta, April 26-27.
Moving the meter for medical device companies using value-based marketing strategies
During the 2016 edition of SEMDA’s flagship conference, Lori Chmura met Paul Snyder, VP of Healthcare for Write2Market after Paul led panel discussion entitled “How Online Presence and Content Marketing Affects Your E-Valuation.” Less than two months later, we partnered with Write2Market to support our content marketing and PR efforts. Among many positive results, our coverage in The Wall Street Journal: “If Surgery Got Cancer In One Try.”
This year, Dune and Write2Market’s relationship will come full circle on the SEMDA stage with Lori providing a C-suite perspective during the healthcare marketing panel. The discussion titled “Beyond the press release: Integrated marketing strategies for medtech and med device” will take place Wednesday April 26th from 2:45 pm-3:45 pm during concurrent session #3.
Lori will sit alongside Michael Krachon, Vice President of Sales & Marketing for Isoray and Deepal Panchal, Program Director, GCMI and T3 Labs. Together they will discuss the why, who and how of building strategic, integrated, value-based marketing programs that drive measurable results even with limited internal teams and compliance constraints.
Women in medtech making a difference
We are particularly excited to reconnect with friends of Dilon during the 2 day conference, especially the network of women leading the medical device industry in the Southeast through engaging Medtech Women@SEMDA. Women account for 73% of healthcare company managers but only 4% of CEOs. And although at Dune, we know and experience daily the value in having women in senior management and executive roles, there are still advancements to be made.That is exactly what Medtech Women@SEMDA aims to accomplish.
Our CEO, Lori Chmura, has been excitingly involved with this organization rallying female medtech industry leaders- knowing that to change the dynamics in the industry, we need all to be part of the effort. The SEMDA 2017 conference sets the stage for the Medtech Women events that will happen throughout the year.
Connect with Dilon Devices during SEMDA 2017
SEMDA provides the perfect opportunity to learn the latest in medtech innovation and medical device investment trends from their source. We are eager to inform the medtech ecosystem what Dune medical devices has been up to as we continue to advance our technology, RF Spectroscopy, and help reduce re-excision rates in lumpectomy with MarginProbe. Are you attending SEMDA 2017? You can hear Lori’s insights during the session described above. For more information about Dilon Devices and MarginProbe, contact firstname.lastname@example.org.